

Cytokinesis completes cell division by constriction of an actomyosin contractile ring that separates the two daughter cells. Here we use the early Caenorhabditis elegans embryo to explore how the actin filament network in the ring and the surrounding cortex is regulated by the single cytokinesis formin CYK-1 and the ARP2/3 complex, which nucleate nonbranched and branched filaments, respectively. We show that CYK-1 and the ARP2/3 complex are the predominant F-actin nucleators responsible for generating distinct cortical F-actin architectures and that depletion of either nucleator affects the kinetics of cytokinesis. CYK-1 is critical for normal F-actin levels in the contractile ring, and acute inhibition of CYK-1 after furrow ingression slows ring constriction rate, suggesting that CYK-1 activity is required throughout ring constriction. Surprisingly, although the ARP2/3 complex does not localize in the contractile ring, depletion of the ARP2 subunit or treatment with ARP2/3 complex inhibitor delays contractile ring formation and constriction. We present evidence that the delays are due to an excess in formin-nucleated cortical F-actin, suggesting that the ARP2/3 complex negatively regulates CYK-1 activity. We conclude that the kinetics of cytokinesis are modulated by interplay between the two major actin filament nucleators. © 2019 Chan et al.
| EMTREE drug terms: | actin related protein 2-3 complexcell proteincyk 1 proteinF actinformin proteinmyosin adenosine triphosphataseunclassified drugactinactin related protein 2-3 complexCaenorhabditis elegans proteincyk-1 protein, C elegans |
|---|---|
| EMTREE medical terms: | actin filamentArticleCaenorhabditis eleganscontrolled studycytokinesisdaughter cellembryononhumanpriority journalregulatory mechanismanimalcell polaritycytologyembryologykineticsmetabolismnonmammalian embryo |
| MeSH: | Actin CytoskeletonActin-Related Protein 2-3 ComplexActinsAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCell PolarityCytokinesisEmbryo, NonmammalianKinetics |
F actin, 39409-31-9; myosin adenosine triphosphatase;
Actin-Related Protein 2-3 Complex; Actins; Caenorhabditis elegans Proteins; cyk-1 protein, C elegans
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| Fundação Portugal Telecom | ||
| ERC-2013-StG-338410-DYNEINOME,FP7/2007-2013 | ||
| European Research Council | ||
| European Social Fund | IF/00901/2013/CP1157/ CT0001,IF/01015/2013/CP1157/CT0006 | |
| Horizon 2020 | 640553 | |
| European Regional Development Fund | ||
| NORTE 2020 | ||
| Federación Española de Enfermedades Raras |
The research leading to these results has received funding from the European Research Council under the European Union’s Horizon 2020 research and innovation program to A.X.C. (grant agreement 640553, ACTOMYO) and under the European Union’s Seventh Framework program (FP7/2007-2013) to R.G. (grant agreement ERC-2013-StG-338410-DYNEINOME). Funding was also provided by the project Norte-01-0145-FEDER-000029–Advancing Cancer Research: From basic knowledge to application, supported by the Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (FEDER). A.X.C. and R.G. have FCT Investigator positions funded by FCT and cofunded by the European Social Fund through Programa Operacional Temático Potencial Type 4.2 promotion of scientific employment (IF/00901/2013/CP1157/ CT0001 to A.X.C. and IF/01015/2013/CP1157/CT0006 to R.G.). F.Y.C. and A.M.S. hold FCT postdoctoral fellowships SFRH/ BPD/93528/2013 and SFRH/BPD/95707/2013, respectively.
Carvalho, A.X.; Instituto de Investigação e Inovação em Saúde (i3S), Portugal;
© Copyright 2019 Elsevier B.V., All rights reserved.